These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9271024)
1. Sudden cardiac death in familial hypertrophic cardiomyopathy: are "benign" mutations really benign? Semsarian C; Yu B; Ryce C; Lawrence C; Washington H; Trent RJ Pathology; 1997 Aug; 29(3):305-8. PubMed ID: 9271024 [TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations. Posen BM; Moolman JC; Corfield VA; Brink PA Br Heart J; 1995 Jul; 74(1):40-6. PubMed ID: 7662452 [TBL] [Abstract][Full Text] [Related]
3. Beta-myosin heavy chain gene mutations and hypertrophic cardiomyopathy in Austrian children. Greber-Platzer S; Marx M; Fleischmann C; Suppan C; Dobner M; Wimmer M J Mol Cell Cardiol; 2001 Jan; 33(1):141-8. PubMed ID: 11133230 [TBL] [Abstract][Full Text] [Related]
4. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy. Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy. Abchee A; Marian AJ J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300 [TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Fananapazir L; Epstein ND Circulation; 1994 Jan; 89(1):22-32. PubMed ID: 8281650 [TBL] [Abstract][Full Text] [Related]
8. Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg-->Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure. Ko YL; Chen JJ; Tang TK; Cheng JJ; Lin SY; Liou YC; Kuan P; Wu CW; Lien WP; Liew CC Hum Genet; 1996 May; 97(5):585-90. PubMed ID: 8655135 [TBL] [Abstract][Full Text] [Related]
9. Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation. Gruver EJ; Fatkin D; Dodds GA; Kisslo J; Maron BJ; Seidman JG; Seidman CE Am J Cardiol; 1999 Jun; 83(12A):13H-18H. PubMed ID: 10750581 [TBL] [Abstract][Full Text] [Related]
10. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations. Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380 [TBL] [Abstract][Full Text] [Related]
11. The Val606Met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age. Havndrup O; Bundgaard H; Andersen PS; Larsen LA; Vuust J; Kjeldsen K; Christiansen M Am J Cardiol; 2001 Jun; 87(11):1315-7. PubMed ID: 11377367 [No Abstract] [Full Text] [Related]
12. Apical hypertrophic cardiomyopathy due to a de novo mutation Arg719Trp of the beta-myosin heavy chain gene and cardiac arrest in childhood. A case report and family study. Döhlemann C; Hebe J; Meitinger T; Vosberg HP Z Kardiol; 2000 Jul; 89(7):612-9. PubMed ID: 10957787 [TBL] [Abstract][Full Text] [Related]
13. A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gln cardiac beta-myosin heavy-chain mutation in a Chinese family. Huang X; Song L; Ma AQ; Gao J; Zheng W; Zhou X; Zhang Q; Lu H; Li Y; Liu Y; Hui R Clin Chim Acta; 2001 Aug; 310(2):131-9. PubMed ID: 11498078 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. Perrot A; Schmidt-Traub H; Hoffmann B; Prager M; Bit-Avragim N; Rudenko RI; Usupbaeva DA; Kabaeva Z; Imanov B; Mirrakhimov MM; Dietz R; Wycisk A; Tendera M; Gessner R; Osterziel KJ J Mol Med (Berl); 2005 Jun; 83(6):468-77. PubMed ID: 15856146 [TBL] [Abstract][Full Text] [Related]
15. A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death. Konno T; Shimizu M; Ino H; Fujino N; Uchiyama K; Mabuchi T; Sakata K; Kaneda T; Fujita T; Masuta E; Mabuchi H Clin Sci (Lond); 2006 Jan; 110(1):125-31. PubMed ID: 16181148 [TBL] [Abstract][Full Text] [Related]
16. A novel missense mutation, Leu390Val, in the cardiac beta-myosin heavy chain associated with pronounced septal hypertrophy in two families with hypertrophic cardiomyopathy. Havndrup O; Bundgaard H; Andersen PS; Larsen LA; Vuust J; Kjeldsen K; Christiansen M Scand Cardiovasc J; 2000 Dec; 34(6):558-63. PubMed ID: 11214007 [TBL] [Abstract][Full Text] [Related]
17. Clinical and genetical heterogeneity of familial hypertrophic cardiomyopathy. Hengstenberg C; Carrier L; Schwartz K; Maisch B Herz; 1994 Apr; 19(2):84-90. PubMed ID: 8194836 [TBL] [Abstract][Full Text] [Related]
18. A murine model for hypertrophic cardiomyopathy. Vikstrom KL; Factor SM; Leinwand LA Z Kardiol; 1995; 84 Suppl 4():49-54. PubMed ID: 8585273 [TBL] [Abstract][Full Text] [Related]
19. Counselling issues in familial hypertrophic cardiomyopathy. Yu B; French JA; Jeremy RW; French P; McTaggart DR; Nicholson MR; Semsarian C; Richmond DR; Trent RJ J Med Genet; 1998 Mar; 35(3):183-8. PubMed ID: 9541100 [TBL] [Abstract][Full Text] [Related]
20. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. Havndrup O; Bundgaard H; Andersen PS; Allan Larsen L; Vuust J; Kjeldsen K; Christiansen M Cardiovasc Res; 2003 Feb; 57(2):347-57. PubMed ID: 12566107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]